AZN and SMMT Related Headlines
Go Back- Summit, AstraZeneca in talks over $15 billion cancer drug licensing deal, Bloomberg News reports
- Summit Therapeutics stock rises after report of potential $15B AstraZeneca deal
- Summit Therapeutics (SMMT) Is Said In Talks For $15 Billion Partnership With Astra (AZN) - Bloomberg

